Evidence map›Paper›PMID 33643376›Full record

ArticleFrontiers in genetics2021

Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic Cancer via Target Gene Regulation.

Bingyi Wang, Yan Xu, Yuhua Wei, Lixin Lv, Nanbin Liu, Rui Lin, Xiuyan Wang, Baomin Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. [Research Progress of Mesenchymal Stem Cells and Their Exosomes on Tumors].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Bingyi WangDepartment of General Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan XuDepartment of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Yuhua WeiDepartment of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Lixin LvDepartment of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Nanbin LiuDepartment of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Rui LinDepartment of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Xiuyan WangDepartment of Ultrasonography, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Baomin ShiDepartment of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Tongji Hospital · CNTongji University · CNTongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to explore the regulatory mechanism of hsa-miR-143-3p and lncRNA RP11-363N22.3-functioning upstream of

methodsWestern blotting and quantitative PCR were used to determine gene expression.

resultshsa-miR-143-3p expression significantly increased in hMSC exosomes than in those in human pancreatic cancer cell line (CFPAC-1) exosomes.

conclusionhsa-miR-143-3p may promote apoptosis and suppress cell growth and invasion in pancreatic cancer.

Indexed as

exosomeslong non-coding RNAsmesenchymal stem cellsmicroRNAspancreatic cancer

Identifiers

PMID33643376
PMCPMC7907650
OpenAlexW3129244666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.